Antibiotics Active Pharmaceutical Ingredient (API) Market Size, Share, Trends, Growth and Forecast 2032

Antibiotics Active Pharmaceutical Ingredient (API) Market Insights

According to the report published by Zion Market Research, the global Antibiotics Active Pharmaceutical Ingredient (API) Market size was valued at USD 8.76 Billion in 2023 and is predicted to reach USD 10.75 Billion by the end of 2032. The market is expected to grow with a CAGR of 2.3% during the forecast period. The report analyzes the global Antibiotics Active Pharmaceutical Ingredient (API) Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Antibiotics Active Pharmaceutical Ingredient (API) Market.

Request Free Sample

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Overview

Antibiotics API is the key ingredient in antibiotics sold in the market. There are different types of antibiotics API available in the market depending on the requirement of the pharmaceutical industry. API is the active ingredient that works against the infection which is why the demand for API is more all over the world.

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Growth Factors

The global antibiotics active pharmaceutical ingredient (API) market is growing at a speedy rate. Factors such as an increase in outsourcing of drug discovery & development programs, an increase in the prevalence of bacterial infections, and an increase in sales of antibiotics are spurring the growth of the global market. Bacterial infections have a major impact on public health. They can be caused at any site of the body and are transmitted to humans through living vectors, food, water, and air. In addition to this, there is a rise in the number of healthcare-associated infections including ventilator-associated pneumonia, central line-associated bloodstream infections, and surgical site infections.

As per the report of the Infectious Disease Society of America (IDSA), every year, around 2 million Americans develop hospital-acquired infections which lead to nearly 99,000 deaths. Thus, to overcome such a huge burden of disease, there is an increase in the uptake of antibiotics surge in the demand for more effective, advanced, and approved antibiotics API molecules all over the world which in turn is propelling the growth of the global antibiotics active pharmaceutical ingredient (API) market. In addition to this, the increase in efficient APIs suppliers to support the production of antibiotics is also one of the key factors that are escalating the growth of the market.

Moreover, factors such as an increase in healthcare expenditure and an increase in initiatives of the government to reduce the mortality rate caused by the infectious disease are fueling the growth of the global market. Furthermore, an increase in R&D activities for the discovery of innovative drugs may offer several opportunities for the growth of the global antibiotics active pharmaceutical ingredient (API) market over the forecast period. However, economic & regulatory disincentives are making it difficult for businesses to develop new antibiotics which may hinder the growth of the global antibiotics active pharmaceutical ingredient (API) market.

With the current onset of the COVID-19 pandemic, many businesses around the world faced temporary shutdown due to strict lockdowns imposed by several governments. Halt on production activities and restrictions on international transport have led to a decline in the global economy. However, the increasing need for antibiotics to curb the spread of COVID-19 infection has positively influenced the growth of the global antibiotics active pharmaceutical ingredient (API) market. Though the antibiotics active pharmaceutical ingredient (API) market growth was affected to some extent during the pandemic period, it is expected to get back on track and register healthy growth over the forecast period.

Request Free Sample

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Segmentation

The global antibiotics active pharmaceutical ingredient (API) market is categorized based on API type, end-use, and region. Based on API type, the global antibiotics active pharmaceutical ingredient market is bifurcated into carbapenem antibiotics, cephalosporins, penicillin antibiotics, and others. The end-use segment comprises contract development & manufacturing organizations (CDMOs), contract manufacturing organizations (CMOs) and pharmaceutical companies.

Antibiotics Active Pharmaceutical Ingredient (API) Market: Report Scope

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Regional Analysis

Asia Pacific is expected to dominate the global antibiotics active pharmaceutical ingredient (API) market. The region holds a large share of the market and China is expected to hold a major share of the market, presence of key API manufactures, and large demand of API from local pharmaceutical players contributing to the larger share of the market in the country. North America is anticipated to stay in the second position on the global antibiotic’s active pharmaceutical ingredient market in terms of market share. The primary factor that is supporting the growth of the market in the region includes a large number of antibiotics manufacturing pharmaceutical players and growing research on API synthesis. Europe is also expected to contribute significant revenue in the global antibiotics active pharmaceutical ingredient (API) market over the forecast period.

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Competitive Players

Due to the competitive nature of the market capital operation, mergers, integration, and acquisitions of small manufactures among large chemical API companies have become gradually frequent. Key players operating in the global antibiotics active pharmaceutical ingredient (API) market include:

• Centrient Pharmaceuticals
• Sandoz International GmbH
• Nanjing Dorra Pharmaceutical Technology Co. Ltd.
• CordenPharma International
• Parabolic Drugs Ltd.
• ACS DOBFAR SPA
• DAEWOONG PHARMACEUTICAL CO. LTD.
• Penam Laboratories Ltd.
• Fresenius Kabi
• ASIATIC DRUGS & PHARMACEUTICALS PVT. LTD.
• The United Laboratories International Holdings Limited, among others.

The Global Antibiotics Active Pharmaceutical Ingredient (API) Market is segmented as follows:
 
By API type 

• carbapenem antibiotics 
• cephalosporins
• penicillin antibiotics 
• and others

By end-use 

• contract development & manufacturing organizations (CDMOs)
• contract manufacturing organizations (CMOs)
• pharmaceutical companies

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.